condition	mean	min	max
0.1 mm CuSO4,WT	0.0	0.0	0.0
1-napp-1,WT	0.0	0.0	0.0
1n,MATa,NaCl,WT	0.0	0.0	0.0
1n,MATa,WT	2.9108125	0.0	65.7152
1n,MATa,unstressed,WT	0.0	0.0	0.0
1n,MATalpha,WT	0.0	0.0	0.0
1n,WT	0.0	0.0	0.0
1n,addition of 1nm-pp1,WT	0.0	0.0	0.0
200 mm hu,WT	0.015588033333333334	0.0	0.0467641
39C,YPD,WT	0.0	0.0	0.0
SC-URA + 20g/l glucose,WT	0.0	0.0	0.0
SDC,WT	0.0	0.0	0.0
WT	0.43333533333333335	0.0	54.8544
YEP + lactic acid + 2% gal,WT	0.0	0.0	0.0
YEP + lactic acid,WT	0.0	0.0	0.0
YP + 3% glycerol,WT	0.0	0.0	0.0
YPD,WT	1.1760956249999999	0.0	11.9398
YPDA,WT	0.0	0.0	0.0
YPEG,WT	0.0	0.0	0.0
azetidine,YPD,WT	0.0	0.0	0.0
cmk treatment,WT	0.0	0.0	0.0
dmso,WT	0.0	0.0	0.0
elutriation + 1nm-pp1,WT	0.0	0.0	0.0
fluco,YPD,WT	0.0	0.0	0.0
gal, 2h + hu 200 mm,WT	0.0	0.0	0.0
gal, 4h + hu 200 mm,WT	0.0	0.0	0.0
gal,WT	0.0	0.0	0.0
glucose,WT	0.0	0.0	0.0
heatshock,WT	0.0	0.0	0.0
hu, 1h,WT	0.0	0.0	0.0
hu, 2h,WT	0.0	0.0	0.0
hu, 4h,WT	0.0	0.0	0.0
log,WT	0.8045652173913043	0.0	18.505
med 35 6aa,WT	0.0	0.0	0.0
med 35 ammonium,WT	0.0	0.0	0.0
med 35 complete,WT	0.0	0.0	0.0
menadione,YPD,WT	0.0	0.0	0.0
mid-log,WT	0.0	0.0	0.0
mid-log,untreated,WT	0.0	0.0	0.0
mid-log,vts1 OE,WT	0.0	0.0	0.0
min med, chemostat,WT	0.0	0.0	0.0
rap,YPD,WT	0.0	0.0	0.0
ribo depletion,WT	0.0	0.0	0.0
salt,YPD,WT	0.0	0.0	0.0
stat,WT	0.0	0.0	0.0
syn dext,WT	22.500041999999997	0.805748	53.5502
synthetic complete med,20C,WT	0.0	0.0	0.0
synthetic defined med,WT	0.0	0.0	0.0
treated,WT	0.0	0.0	0.0
tunicamycin,YPD,WT	0.0	0.0	0.0
untreated,WT	0.0	0.0	0.0
ypsorbitol (2.02%),YPD,WT	0.0	0.0	0.0